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Abstract
While human embryonic stem cells (hESCs) and human embryonal carcinoma cells (hECCs) have been studied extensively at
the levels of the genome, transcriptome, proteome and epigenome our knowledge of their corresponding metabolomes is
limited. Here, we present the metabolic signatures of hESCs and hESCs obtained by untargeted gas chromatography
coupled to mass spectrometry (GC-MS). Whilst some metabolites are common to both cell types, representing the self-
renewal and house-keeping signatures, others were either higher (e.g., octadecenoic acid, glycerol-3-phosphate, 4-
hydroxyproline) or lower (e.g., glutamic acid, mannitol, malic acid, GABA) in hESCs (H9) compared to hECCs (NTERA2), these
represent cell type specific signatures. Further, our combined results of GC-MS and microarray based gene expression
profiling of undifferentiated and OCT4-depleted hESCs are consistent with the Warburg effect which is increased glycolysis
in embryonic cells and tumor cells in the presence of O2 while oxidative phosphorylation (OXPHOS) is impaired or even shut
down. RNAi-based OCT4 knock down mediated differentiation resulted in the activation of the poised OXPHOS machinery
by expressing missing key proteins such as NDUFC1, UQCRB and COX, increase in TCA cycle activity and decreased lactate
metabolism. These results shed light on the metabolite layer of pluripotent stem cells and could potentially establish novel
metabolic markers of self renewal and pluripotency.
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Introduction
Pluripotent human embryonic stem cells (hESC) find their
malignant counterpart in human embryonal carcinoma cells
(hECCs) [1,2,3]. Pluripotency, defined as the ability to self-renew
while retaining the capacity to differentiate into all lineages of the
embryo proper make hESCs great candidates for regenerative
therapies. Both properties are invaluable for this purpose, because
they insure both, a constant supply in vitro and, at least equally
important, the generation of therapy needed tissue or cells. This is
especially thought to hold true for hESCs, because they are truly
pluripotent. hECCs are somewhat more restricted, but serve as
a useful model for both, carcinogenesis in pluripotent tissues and
for studying self renewal [4,5]. In particular the latter is interesting
for the stem cell field, because in contrast to hESCs, hECCs are
easier to culture, cheaper, do not require the co-culture with
a feeder layer and display more robustness, i.e. almost no
spontaneous differentiation. A pre-requisite for clinical applica-
tions, however, is to understand not only the developmental and
differentiation processes, but also the undifferentiated state of the
hESCs. The undifferentiated state has been extensively investigat-
ed in hESCs and due to historical reasons even more so in hECCs.
Apart from developmental aspects most of our knowledge on
hESCs and hECCs is restricted to morphological, cellular,
subcellular, transcriptional and protein levels. Both hESCs and
hECCs are round, small, display a high nuclear/cytoplasmic ratio
that dramatically decreases upon differentiation, they contain 1 to
3 prominent nucleoli, the chromatin is rather euchromatic than
heterochromatic and they lack or display a shortened G1 phase
[1,3,6]. However, hESCs grow as colonies unlike hECCs which
grow as a monolayer. Despite this difference, both cell types
express a variety of common markers on the cell surface – alkaline
phosphatase, SSEA3, SSEA4, TRA1-60, but they are negative for
SSEA1 [1,3]. They also express other markers like the core
transcription factors OCT4, SOX2, NANOG [4,5,7,8] - that are
required to reprogram somatic cells [9,10] - or the signaling
molecules like TGFb, NOTCH, WNT [11,12,13,14,15].
Although many studies have characterized hESCs and hECCs
only very few studies investigated the composition of the
metabolome of human pluripotent stem cells [16,17]. This is
rather surprising given that the metabolites and receptor-ligand
interactions are amongst the first cell sensors to react to
environmental changes. On the other hand many metabolites
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for a long time. With the advent of new available technologies like
GC-MS and LC-MS, however, it is now possible to assess
metabolic profiles. The first study to our knowledge was conducted
by Cezar and colleagues who investigated the secreted metabo-
lome of three independent hESC lines and hESC derived neural
precursors cells (hNPs) using a liquid chromatography (LC)-
electrospray ionization (ESI)- time of flight (TOF) mass spectrom-
etry (MS) approach (LC-ESI-TOF MS) [16]. They detected
hundreds of unknown metabolites produced and secreted by both
cell types and showed that exposure to valproic acid - a histone
deacetylase inhibitor - induced significant changes in a subset of
metabolites in hESCs compared to the hNPs [16]. A similar study
was performed by Yanes et al. [17]. They investigated the
metabolome of murine undifferentiated embryonic stem cells
(mESCs) and differentiated mESCs into neurons and cardiomyo-
cytes using an untargeted LC-ESI-MS approach and found that
a significant proportion of the metabolites of undifferentiated
mESCs are unsaturated carbohydrates. The balance shifted to
saturated compounds as soon as the cells differentiated. Hereby, it
seems as if the redox potential established by the GSH/GSSG
ratio, which decreases upon differentiation, and the ascorbic acid
levels, which behave reciprocally upon differentiation, are the
driving forces [17]. Panopoulos et al. described recently in an
untargeted LC-MS approach that somatic cells undergo a meta-
bolic shift upon reprogramming to iPS cells and that this shift is
required for this process to take place [18].
Here, we present the metabolic signatures of the hESC line (H9)
and their malignant counterpart hECCs (NTERA2 cl.D1) using
an optimized protocol for metabolite extraction using a GC-MS
approach adapted to day-to-day culture. This study does not only
highlight the metabolic signature of human pluripotent stem cells,
but also sheds light on their cancer biology.
Results
Establishment of a Metabolite Detection Protocol for
hESCs and hECCs
In order to successfully analyze and compare the metabolomes
of hESCs and hECCs we have modified and optimized the
protocol of metabolite extraction described by Bennett et al. 2008
[19]. We adapted it to day-to-day culture conditions of hESCs and
hECCs rendering it suitable to analyze the extracts for untargeted
metabolome analysis with GC-MS. First, a washing step with
sodium chloride in physiological concentrations was introduced to
remove media components from the cells before extraction to
minimize any potential noise. This is important as the medium
used for the cultivation of eukaryotic cells is complex and contains
metabolites that are also present in the cells, e.g. amino acids and
sugars in high concentrations. Remaining media components
attached to the cells after cultivation would interfere with the
relative quantification of intracellular metabolites. A second reason
for adapting the protocol for day-to-day culture of hESCs is that
large scale culture is costly. We started with as high as 1.5610
7
hECCs to insure maximal metabolite detection. Cell numbers
were then stepwise reduced to 1610
6 cells and below. We were
able to implement the same protocol for hESCs. From this step
onwards the routinely used cell number for metabolite extractions
was 1610
6 cells per technical replicate.
Identified Metabolites
The optimised protocol was used for the analysis of the human
embryonal carcinoma cell line NTERA2, cl.D1 (hECC) as well as
the human embryonic stem cell line H9 (hESC). For both cell
types, four biological replicates with two technical replicates each
were analyzed. The untargeted GC-MS analysis of the hESCs and
hECCs samples resulted in the detection of 161 metabolites of
which 57 could not be structurally identified (Tables 1–3 and
Table S1). The mean relative standard error after normalization
over the 4 biological replicates of the hECCs and hESCs samples
was 7.4% and 11.2%, respectively. Figure 1 shows a scatterplot of
the normalized peak areas of all substances detected in hESC
versus hECC cells. As can be seen in the figure, many metabolites
are present in nearly equal amounts, whereas others vary
significantly between the two cell types. Taken together, the
analysis revealed 68 metabolites that occur in same concentrations
in both cell lines (less than 2-fold regulated), 43 metabolites that
are higher (more than 2-fold) and 50 that are lower (less than 0.5
fold) concentrated in hESCs compared to hECCs (Table 1–3). All
groups contained also unknown metabolites (Table S1). In
addition, figure 2 displays those metabolites that differ significantly
between hESCs and hECCs according to a T-test performed with
MeV with a p-value of ,0.05 (adjusted Bonferroni correction)
[20,21].
Metabolites with Unmodified Concentration in hESCs
and hECCs
This group contained several amino acids, intermediates of the
glycolysis pathway (glyceric acid-3-phosphate, dihydroxyacetone
phosphate, glucose-6-phosphate), some sugars and sugar acids,
nucleotides (guanosine, adenosine, 5-AMP, 5-GMP), some fatty
acids (hexadecanoic acid, octadecanoic acid), as well as the
diamine putrescine and its precursor ornithine (Table 1). Taken
together the identified metabolites play a role in energy generation
like glycolysis, but also in nucleotide metabolism, protein bio-
synthesis, lipid metabolism and others. Additionally, several
unknown metabolites were found (Table S1). This group of
metabolites constitutes the pluripotency signature besides house-
keeping metabolites. The two groups of metabolites present in
different concentrations in the two different cell lines represent cell
type specific differences that contribute to the understanding of the
hESCs and hECCs (Table 2–3).
Metabolites with Higher Concentrations in hESCs
Compared to hECCs
The metabolites increased in the hESCs in comparison to the
hECCs contained some amino acids and intermediates of amino
acid degradation, several fatty acids, especially unsaturated ones
(docosahexaenoic acid, octadecadienoic acid), lipid precursors like
glycerol-3-phosphate and phosphoethanolamine, and several un-
identified compounds whose mass spectra show similarities to
sterols (group 1) as well as 4-hydroxyproline (Table 2 and Table
S1). Additionally, the levels of ascorbic acid were much higher (5.2
fold) compared to hECCs, as well as the polyamine spermidine
(2.6 fold). The metabolites of this group are involved in protein
biosynthesis, lipid metabolism and extra-cellular matrix remodel-
ing (4-hydroxyproline).
Metabolites with Lower Concentration in hESCs
Compared to hECCs
This group contained several amino acids (alanine, glutamic
acid, glutamine, beta-alanine), the sugar alcohols erythritol and
mannitol, several intermediates of the citric acid cycle (malic acid,
fumaric acid, 2-oxoglutaric acid and succinic acid), creatinine, the
neurotransmitter 4-aminobutanoic acid (GABA) and some un-
identified components (Table 3 and Table S1).
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Ratio hESC/hECC Metabolite Info Significance
1
0.912 Arginine amino acid
1.868 Asparagine amino acid
0.532 Aspartic acid amino acid
0.837 Cysteine amino acid
1.308 Glycine amino acid
1.266 Ornithine amino acid
1.791 Serine amino acid **
1.434 Serine, N-acetyl- amino acid
0.672 Tyrosine amino acid
0.514 Leucine amino acid, essential *
0.707 Lysine amino acid, essential
0.866 Methionine amino acid, essential
1.865 Threonine amino acid, essential
1.007 Trehalose disaccharide
1.815 Eicosatetraenoic acid fatty acid
1.322 Hexadecanoic acid fatty acid
0.928 Hexadecenoic acid fatty acid
1.611 Octadecanoic acid fatty acid
1.945 Octadecenoic acid fatty acid
0.711 Hexadecanol fatty alcohol
0.961 Dihydroxyacetone phosphate Glycolysis
1.475 Fructose-6-phosphate Glycolysis
1.340 Glucose Glycolysis
1.266 Glucose-1-phosphate Glycolysis
1.263 Glucose-6-phosphate Glycolysis
0.673 Glyceric acid-3-phosphate Glycolysis
1.045 Lactic acid, DL- Glycolysis
1.318 *Glycerol lipids
0.544 Cholesterol membrane
0.874 Adenosine nucleotides
0.778 Adenosine-5-monophosphate nucleotides
0.806 Guanosine nucleotides
0.730 Guanosine-5-monophosphate nucleotides
1.068 Thymine nucleotides
1.052 Uracil nucleotides
1.582 Putrescine diamine
1.171 *Galactose sugar
1.694 Maltose sugar
0.801 Gluconic acid-1,5-lactone sugar acid
0.582 Glyceric acid sugar acid *
1.773 Xylitol sugar alcohol
0.638 Glucose, 1,6-anhydro, beta- sugar degradation
1.523 D-Sedoheptulose-7-phosphate sugar phosphate
1.144 Nicotinamide vitamine B3
0.525 Pantothenic acid vitamine B5 **
0.835 myo-Inositol-2-phosphate
0.937 Phosphoric acid
Metabolites present in DMEM medium written in bold.
1Statistical significance was determined by a T-test with adjusted Bonferroni correction in MeV. P-values ,0.05 marked as *, p-values ,0.01 marked as **.
doi:10.1371/journal.pone.0039896.t001
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and Differentiated hESCs to the Corresponding
Metabolome
Microarray based gene expression profiling was performed on
undifferentiated hESCs by utilizing our previously published
microarray-based data set pertaining to RNAi-based knockdown
of OCT4- a major pluripotency maintenance factor - in the
human ES line H1 [5,15]. Indeed, we were able to confirm the
regulation of genes and their associated pathways corresponding
to the detected metabolites by GC-MS analysis. Examples of
these include the intermediates of the glycolysis, the citric acid
cycle, fatty acid metabolism, as well as various pathways of
amino acid degradation and biosynthesis. However, we were
also able to identify additional pathways using the microarray
data. For example, we found transcripts encoding for enzymes
involved in the pentose phosphate pathway, fructose and
mannose metabolism, glutathione metabolism, glycosphingolipid
biosynthesis, GPI-anchor biosynthesis, steroid biosynthesis and
many others [22].
Substantiating the Warburg Effect
The Warburg effect describes the feature of tumor cells and
embryonic cells to shift their main energy (ATP) source under
aerobic conditions from oxidative phosphorylation to glycolysis
[23,24]. With the increased dependency on glycolysis and the
regeneration of reduction equivalents like NADPH+, lactate
production increases as well. In order to assess whether this is
the case in our cell types of interest we analyzed our above
mentioned microarray data sets and analyzed the downstream
gene regulatory networks [4,5,15].
We found several indications like increased glycolysis and
reduced oxidative phosphorylation substantiating this hypothesis
(Table 4). Essential genes associated with various cytochrome
complexes of the oxidative phosphorylation machinery are not
expressed in the undifferentiated state and are induced upon
OCT4 knockdown mediated differentiation. However, we found
the remaining complex oxidative phosphorylation machinery to be
expressed with all its protein subunits of the various complexes that
are embedded in the mitochondria. The few non-expressed
Table 2. Metabolites more than 2-fold higher in hESC compared to hECC cells.
Ratio hESC/hECC Metabolite Info Significance
1
7.080 Proline amino acid
7.403 Isoleucine amino acid, essential **
5.621 Phenylalanine amino acid, essential *
5.803 Tryptophan amino acid, essential **
4.343 Valine amino acid, essential
2.088 2-oxo-Isovaleric acid valine degradation
5.436 3-Methyl-2-oxopentanoic-acid isoleucine degradation **
27.402 Kynurenine Tryptophan degradation
4.298 Docosahexaenoic acid fatty acid *
3.319 Heptadecanoic acid fatty acid
132.863 Octadecadienoic acid fatty acid *
hESC only *Oleic acid amide fatty acid amide
4.010 Octadecanol fatty alcohol
2.214 2-Monooleoylglycerol lipids
2.469 Glycerol-2-phosphate lipids **
4.314 Glycerol-3-phosphate lipids
110.622 Phosphoethanolamine lipids
4.497 4-Hydroxyproline membrane *
2.405 Thymidine-59-monophosphoric-acid nucleotides **
2.552 Spermidine polyamine
2.027 Lyxose sugar
5.186 Xylulose sugar *
3.407 *Galacturonic acid sugar acid
4.103 Gluconic acid sugar acid *
3.398 Gulonic acid sugar acid *
2.015 Citric acid TCA cycle **
5.195 Ascorbic acid vitamine C
3217.587 Dehydroascorbic acid dimer vitamine C **
4.734 Cholecalciferol, 25-hydroxy- vitamine D3
2.012 Pyrophosphate
Metabolites present in DMEM medium written in bold.
1Statistical significance was determined by a T-test with adjusted Bonferroni correction in MeV. P-values ,0.05 marked as *, P-values ,0.01 marked as **.
doi:10.1371/journal.pone.0039896.t002
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subunit of the NADH dehydrogenase (complex I) that transfers
electrons from NADH to the respiratory chain essential for the
oxidative phosphorylation [25]. Secondly, UQCRB is a gene
encoding a protein which is part of the ubiquinol-cytochrome c
oxidoreductase complex (complex III) [26]. This complex contains
ten nuclear-encoded and one mitochondrial-encoded subunit and
is involved in redox-linked proton pumping. The protein binds
ubiquinone and contributes to the transfer of electrons when
ubiquinone is bound. Mutations in the human gene cause
a complex III deficiency resulting in hypoglycaemia and lactic
acidosis [27].
Thirdly, subunits of the cytochrome c oxidase (COX), the
terminal component of the mitochondrial respiratory chain that
catalyzes the electron transfer from reduced cytochrome c
(complex IV) to oxygen. The mitochondrially-encoded subunits
function in electron transfer, and the nuclear-encoded subunits
may function in the regulation and assembly of the complex.
Discussion
Human embryonic stem cells as well as human embryonal
carcinoma cells have been heavily investigated at the genomic,
transcriptomic, epigenomic and proteomic levels, but metabo-
lome studies have not been extensively employed. To our
knowledge, this is the first study to employ an untargeted GC-
MS approach to analyze the global metabolome of hESCs and
hECCs. This is of importance, because the challenge in the field
of hESC research is to find an approach that allows the
detection of metabolites from as little starting material as hESCs
day-to-day culture can provide. We adjusted our protocol to be
as gentle as possible in order to preserve as many metabolites as
possible. We removed the medium and replaced it with ice cold
washing buffer on ice and then extracted with prechilled
(220uC) extraction solution on ice.
Using this approach our metabolome analysis of hESCs of
hECCs revealed three groups of metabolic signatures which will
add to the understanding of self renewal in hESCs and hECCs.
Firstly, the metabolites present in similar concentrations in both
cell types, hESC and hECCs. These metabolites constitute the
pluripotency signature besides housekeeping metabolites. Second-
ly, the metabolites which are present in higher quantities in hESCs
compared to hECCs and, thirdly, vice versa. The latter two
constitute cell type specific signatures and will contribute to a more
detailed understanding of the various types of human pluripotent
stem cells.
Table 3. Metabolites more than 2-fold lower in hESC compared to hECC cells.
Ratio hESC/hECC Metabolite Info Significance
1
0.389 5-Oxoproline amino acid **
0.211 Alanine amino acid *
0.173 Alanine, beta- amino acid
0.294 Glutamic acid amino acid
0.415 Glutamic-acid_methylester amino acid
0.250 Glutamine, DL- amino acid *
0.411 Histidine amino acid, essential **
0.484 Cystathionine cysteine biosynthesis *
0.177 Cysteinesulfinic acid cysteine biosynthesis **
0.025 Taurine cysteine, methionine degradation
0.265 Sorbitol disaccharide **
0.367 *Pyruvic acid Glycolysis
0.099 *4-aminobutanoic acid neurotransmitter *
0.398 Adenine nucleotides *
0.134 Uridine nucleotides *
0.483 Fructose sugar
0.361 Threonic acid sugar acid *
0.255 *Mannitol sugar alcohol *
0.203 Erythritol sugar alcohol *
0.121 myo-Inositol sugar alcohol *
0.173 2-Hydroxyglutaric-acid TCA cycle **
0.145 2-oxo-Glutaric acid TCA cycle **
0.489 Fumaric acid TCA cycle **
0.349 Malic acid TCA cycle
0.422 Succinic acid TCA cycle
0.043 Creatinine *
0.176 Hypotaurine
Metabolites present in DMEM medium written in bold.
1Statistical significance was determined by a T-test with adjusted Bonferroni correction in MeV. P-values ,0.05 marked as *, P-values ,0.01 marked as **.
doi:10.1371/journal.pone.0039896.t003
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quantities like glycolysis intermediates. These results were verified
by the transcriptomic data obtained by microarray based gene
expression profiling of undifferentiated hES cells. Taken together,
these results substantiate the Warburg effect which is the reliance
of embryonic cells and cancer cells on glycolysis rather than
oxidative phosphorylation under aerobic conditions. In order to
further substantiate these data, we compared gene expression data
from undifferentiated cells with OCT4 depleted cells. Indeed, we
managed to identify key components of the various essential
mitochondrial respiratory chain complexes like NDUFC1, UQCRB
and cytochrome c oxidase, to be upregulated only upon
differentiation. This strongly indicates that the oxidative phos-
phorylation machinery is only fully active in differentiated cells -
when they leave the stem cell compartment. However, the
majority of the oxidative phosphorylation components are already
expressed on mRNA level suggesting that the whole machinery is
in a poised like state and ready to go reminding of the epigenetic
poised states of simultaneous methylation of active and inactive
marks, H3K4 and H3K27 [28], respectively. Regarding the
metabolic state our results are in agreement with Prigione et al.
2010 [29] and Panopoulos et al. [18] demonstrating that upon
cellular reprogramming, somatic cells shift their energy supply
from oxidative phosphorylation to glycolysis.
It is noteworthy that the TCA and TCA cycle intermediates are
enriched in hECCs in comparison to the hESCs. This might
indicate that the cancerous hECCs could rely less on the Warburg
effect than the hESCs. The TCA cycle is upstream and closely
linked with the oxidative phosphorylation. The TCA cycle takes
place in the mitochondrial matrix and the generated NADH is fed
into oxidative phosphorylation taking place in the mitochondrial
membranes. In line with this arguement, we found that xylulose,
a ketopentose which is present in the cells as xylulose-5-phosphate
as an intermediate of the pentose-phosphate pathway, is present in
the hES cells in 5-fold excess compared with the hEC cells.
Notably, xylulose-5-phosphate can be converted to glyeraldehyde-
3-phosphate which can feed into glycolysis. Here, it can be
converted to 1,3-bisphosphoglycerate, an energy rich compound
that will be used to generate ATP and NADH. Moreover,
xylulose-5-phosphate has also a signaling function which leads to
the amplification of glycolysis. Further, xylulose-5-phosphate
signaling functions extend to glucose induced lipogenisis [30].
Together with 4-fold higher quantities of glycerol-3-phosphate
which is a compound of the glycerophospholipids and 110-fold
higher levels of phosphoethanolamine which in turn is a precursor
of phosphatidylethanolamine, a major component of the mem-
brane lipids and a growth factor in mammalian tumors, it seems
plausible to assume that hESCs and hECCs might have different
membrane compositions. However, it is possible that this is
a consequence of the elevated signaling sphingolipid S1P
degradation which is known to be an important pluripotency
factor that acts through ERK1/2 activation [31]. Like many
metabolites glycerol-3-phosphate is multifunctional and it shuttles
the reduction equivalents to the mitochondria, presumably, to
prepare the hESCs for differentiation.
The large difference of the 4-hydroxyproline concentration (4.5-
fold) higher in hESCs indicated that the composition of the extra-
cellular matrices is different between the two investigated cell
types. According to this, also proline (7-fold), which is the
precursor of 4-hydroxyproline as well as ascorbic acid (5-fold),
the cofactor of the 4-hydroxyproline biosynthesis were strongly
upregulated in hESCs.
Further, it is noteworthy that various cell membrane compo-
nents like octadecadienoic acid and some unidentified components
similar to sterols (group 1) are present in much higher quantities in
hESCs than in hECCs (octadecadienoic acid 132-fold, docosahex-
aenoic acid 4.3-fold, heptadecanoic acid 3.3-fold, octadecenoic
acid 2-fold and various unidentified components similar to sterols
Figure 1. Scatter-plot of normalized peak areas of metabolites detected in hESCs versus hECCs. Only metabolites with more than 3-fold
difference are named. Error bars are the standard error.
doi:10.1371/journal.pone.0039896.g001
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incorporated in membranes and influence the fluidity of cell
membranes for example. It is known that cholesterol as well as
unsaturated fatty acids disrupt the aligned fatty acids of the cell
membranes and therefore counteract the viscosity of the cell
membranes. It is possible that the low transfection efficiencies of
human pluripotent stem cells and in particular of human
embryonic stem cells are associated with its special membrane
composition. Consequently, it is justified to speculate that the
currently available inefficient lipofection reagents for hESCs and
hECCs might be improved significantly if they were adjusted in
their lipid vesicle composition to the target membranes of these
cell types. Many unsaturated fatty acids have been detected in
both cell lines, whereby the concentration is higher in hESCs
compared to hECCs. The v-3 fatty acid, octadecadienoic acid, is
more than 130-fold higher concentrated in hESCs than in hECCs
while eicosatetraenoic acid was only 1.8 fold higher. It has been
shown by Yanes et al. that unsaturated compounds are
characteristics of embryonic stem cells, enabling the eradication
of reactive oxygen species occurring during differentiation [17].
Following Panopoulos et al. it seems that transmethylation, cellular
respiration and energy are necessary changes for reprogramming
cause they are functionally shown to affect reprogramming [18].
Another metabolite that was higher (27-fold) in hESCs than in
hECCs is kynurenine. It is an aromatic non-proteinogenic amino
acid that is a product of the degradation of the essential amino
Figure 2. Heat map representing the relative quantities of significantly changed metabolites from polar extracts of hESC versus
hECCs. Statistical analysis (T-Test) was done with MeV (p-value ,0.05).
doi:10.1371/journal.pone.0039896.g002
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NMDA receptor antagonist and displays neuroprotective proper-
ties in animal models. Also, it is an intermediate for the synthesis of
NAD [32]. Our metabolome data do not indicate which sub-
branch of the kynurenine pathway is active. However, the
transcriptome data indicate that the levels of KATI and KATIII,
two of three kynurenine amino transferases that convert kynur-
enine to kynurenic acid which in turn is a broad spectrum
antagonist of excitatory amino acid receptor, are almost 2-fold
down regulated and 1.7-fold upregulated, respectively, upon
differentiation mediated by OCT4 depletion. In addition, L-
kynurenine hydrolase (KYNU) is 2.4-fold upregulated. KYNU is
involved in the kynurenine sub-branch which synthesizes NAD
[33]. And therefore, the difference in kynurenine levels could also
be reflecting the truly pluripotent properties of hESCs in
comparison to the more restricted pluripotential of hECCs.
hECCs have a reduced capacity to differentiate into all
embryonic tissues compared to hESCs. Instead, they have
sustained/enhanced their proliferative capacity. In agreement
with this is the lower abundance of some amino acids in hECCs in
our GC-MS analysis that are required for protein biosynthesis. On
the other hand the metabolites detected in higher quantities in
hECCs in comparison to hESCs are associated with proliferation,
for example higher GABA levels. It is known that GABA and its
receptors, in particular the subunit GABRB3, maintain the
undifferentiated state and correlate in particular with proliferation
[34,35]. We cannot exclude the possibility that the elevated GABA
levels are not associated with the bias of hECCs to differentiate
towards neurons.
In the stem cell field, Waddington’s model of the epigenetic
landscape is widely discussed and accepted. However, increasingly
more pieces of evidence indicate that the first differentiation
hurdle to commit to differentiation, as many postulate, does not
exist - at least in vivo. The Waddington model describes
(embryonic) development in terms of the ‘‘epigenetic landscape’’
(gene expression/thermodynamically) aiming to reach the lowest
energy state (differentiation/death). Arguments against this first
differentiation barrier come from various levels, the genetic,
epigenetic and the metabolic. First, in 2011, Loh et al. provided
convincing arguements that key pluripotency factors, like OCT4,
Table 4. List of metabolite associated pathways in OCT4 depleted hESCs compared to EGFP depleted control cells.
No. of pathway enriched
genes Difference in gene numbers
KEGG_Pathway OCT4 KD EGFP KD OCT4 KD EGFP KD
hsa03040:Spliceosome 114 113 1
hsa03018:RNA degradation 51 50 1
hsa00970:Aminoacyl-tRNA biosynthesis 39 38 1
hsa00240:Pyrimidine metabolism 76 74 2
hsa00190:Oxidative phosphorylation 98 94 4
hsa00020:Citrate cycle (TCA cycle) 27 27 0 0
hsa00563:Glycosylphosphatidylinositol(GPI)-anchor biosynthesis 23 22 1
hsa00310:Lysine degradation 38 34 4
hsa00280:Valine, leucine and isoleucine degradation 39 36 3
hsa00520:Amino sugar and nucleotide sugar metabolism 39 38 1
hsa00480:Glutathione metabolism 37 35 2
hsa00562:Inositol phosphate metabolism 39 34 5
hsa00100:Steroid biosynthesis 16 14 2
hsa00510:N-Glycan biosynthesis 41 35 6
hsa00230:Purine metabolism 108 98 10
hsa00030:Pentose phosphate pathway 22 21 1
hsa00640:Propanoate metabolism 27 25 2
hsa00270:Cysteine and methionine metabolism 26 26 0 0
hsa00051:Fructose and mannose metabolism 26 26 0 0
hsa01040:Biosynthesis of unsaturated fatty acids 18 17 1
hsa00100:Steroid biosynthesis 16 14 2
hsa00450:Selenoamino acid metabolism 20 19 1
hsa00564:Glycerophospholipid metabolism 47 47 0 0
hsa00533:Keratan sulfate biosynthesis 12 9 3
hsa00620:Pyruvate metabolism 26 27 1
hsa00900:Terpenoid backbone biosynthesis 13 13 0 0
hsa00010:Glycolysis/Gluconeogenesis 38 38 0 0
hsa04115:p53 signaling pathway 54 50 4
Shown are the numbers of genes and their difference enriched for the specific pathways.
doi:10.1371/journal.pone.0039896.t004
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undifferentiated state, but lineage specifiers [36]. Indeed, the
expression of these factors is required for the true pluripotent state
and this is also the very reason for their requirement in the
generation for iPS cells, but their function is also essential to
determine the germ layers and downstream differentiation [36]
(references therein), [37]. Secondly, the bivalent chromatin state,
in form of simultaneous occurring active and repressive methyl-
ation marks of histone 3 lysine 4 and lysine 27, respectively [28],
indicates that this poised state keeps the cells prepared to enter the
differentiation process without any roadblocks and to remove any
silencing mechanisms. Further, we show in this study that
glycolysis and the TCA cycle are fully operative and that the
oxidative phosphorylation machinery is largely expressed apart
from one factor in almost each of the essential complexes of the
respiratory chain – in a poised state.
In agreement with this, we found fatty acids susceptible to
oxidation. Decreasing GSH/GSSG ratios that alter the redox
potential and probably start the oxidizing processes of several
substrates lead to differentiation [17]. It seems as if none of these
three levels, genetic, epigenetic and metabolic, aim at trapping the
cells in the pluripotent state, but almost the opposite. And, indeed,
the truly pluripotent cells exist in a very short time window apart
from the germ cells when set into the context of the life span of
mammals.
We acknowledge that multiple ESC and ECC lines would have
been the optimal for our current study, however, we believe our
analysis is robust and representative for the following reasons.
First, the international stem cell initiative characterized a large
number of distinct human embryonic stem cell lines and showed
that they are very similar in their characteristics, for example, the
expression of key transcription factors, surface antigens, and other
features [38]. The human embryonic stem cell line H9 used in this
study is a representative cell line of these features and was included
in the mentioned study.
Second, Greber et al. and Andrews et al. previously demon-
strated that hESCs and hECCs share fundamental features and
that human embryonal carcinoma cells constitute the malignant
counterpart of human embryonic stem cells [4,39,40]. For
example the cellular morphology, the expression of the key factors
OCT4/SOX2/NANOG, the expression of surface antigens
SSEA4, SSEA3, TRA 1–60, TRA 2–54, TRA 1–80, and many
others.
Third, in our previous study, Greber et al. [4] we used RNAi-
mediated knockdown of OCT4, SOX2 and NANOG to
demonstrate similar effects in three hECC lines, namely NCCIT,
2102Ep and NTERA2. Based on these findings we decided to use
the NTERA2 line for our current study.
Human embryonic stem cells (hESCs), in contrast to human
embryonal carcinoma cells (hECCs), require besides autocrine
bFGF also paracrine bFGF which has been shown for many hESC
and hECC cell lines [3,4,34,41]. Therefore, it is essential for
hESCs that their culture medium is supplemented with bFGF
whereas it is not required for hECCs. Due to this fact it is difficult
to formulate a medium which is tailored to the minimal
requirements of both cell types simultaneously. However, despite
these differences both cell types share reliance on fundamental
signaling pathways (e.g. FGF signaling, the Activin/Nodal axis of
TGFß signaling and ERK/MAPK signaling) and the core
transcription factors OCT4, SOX2 and NANOG to maintain
the undifferentiated state and knockdown of these transcription
factors in either hESCs or hECCs induces differentiation
[4,7,36,37].
Conclusion
Taken together our combined data clearly illustrate that the
analysis of metabolic signatures obtained by the untargeted GC-
MS approach is an important step towards the understanding of
human pluripotent stem cells and probably constitute only the tip
of the ice berg. This and future studies will help to establish novel
pluripotency and differentiation markers at the metabolite level
and help to increase our meagre understanding of the nature of the
pluripotent state.
Materials and Methods
Growth of Adherent Cells
The hESC line H9 was cultured in knock-out serum re-
placement medium that was conditioned with mouse embryonic
fibroblasts. The human embryonal carcinoma cells (NTERA2cl.
D1,) were grown in DMEM, 10% FBS Serum (Biochrom). Both
cell types were cultivated at 37uC in a humidified 5% CO2
atmosphere using tissue culture plastic from TPP.
Metabolome Analysis
The quenching procedure adapted from Bennett et al. [19] was
optimised as follows: Cells were grown in 25 cm
2 tissue culture
flasks until the desired time point resulting in about 223610
6
cells. The cells were washed twice with 5 ml ice-cold 0.9% NaCl
solution to remove remaining medium components. The cells were
quenched with 1.5 ml extraction solution (80% methanol contain-
ing ribitol (2 mg/ml) as a standard for normalization purposes) and
the flasks chilled at 220uC for 5 min. The cells were scraped off
from the flask, resuspended in the extraction solution and
transferred to centrifugation tubes. After centrifugation (4uC,
9,0006g, 3 min), the supernatant was collected and the cell pellet
was again resuspended in 0.5 ml extraction solution and
centrifuged again (4uC, 9,0006g, 3 min). The supernatants were
pooled, mixed and split into 261 ml samples, dried under vacuum
at room temperature and stored at 220uC until derivatization.
Sample Derivatization
At first, samples were dried for 30 min under vacuum prior
derivatisation. The pellets were derivatized in 40 ml pyridine
containing 20 mg/ml methoxyamine hydrochloride at 30uC for
90 min under constant mixing. After addition of 70 ml MSTFA
(N-methyl-N-trimethylsilyltrifluoroacetamide), samples were in-
cubated for 30 min at 37uC followed by 2 h at 25uC with
constant agitation. The samples were centrifuged at 14,0006g for
5 min and the supernatants were transferred into glass vials for
GC-MS analysis. All samples were analyzed within 24 h after
derivatization. A retention index marker (n-alcanes ranging from
C10…C36 in cyclohexane) was used to convert retention times to
retention index.
Data Acquisition by GC-EI-MS
GC-MS analysis was done on a Thermo GC Ultra coupled to
a DSQII mass spectrometer equipped with an AS3000 auto-
sampler (ThermoScientific, Dreieich, Germany). In summary, 1 ml
of the derivatized sample was injected in split mode (1:25) into
a PTV injector (ThermoScientific, Dreieich, Germany). After an
initial time of 0.2 min at 70uC, temperature was increased to
330uC at a rate of 14uC/s, followed by an additional constant
temperature period at 330uC for 5 min. Gas-chromatography was
performed over 60 min on a DB-5MS column (30 m60.25 mm
I.D.) (J&W Scientific, Folsom, USA). Helium flow was set to 1 ml/
min. After 1 min at 70uC, temperature was ramped to 76uC with
1uC/min and then increased to 310uC with 6uC/min followed by
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line temperature was set to 275uC. Ion source temperature was
adjusted to 220uC. Full scan mass spectra were acquired from m/z
40…460 with an acquisition rate of 2.5 scans/s. Solvent delay time
was 5.15 min. Data acquisition was done using the Xcalibur
software (version 1.4, ThermoScientific).
Additionally the samples were analysed using the Leco Pegasus
4D GCxGC-TOFMS in GC-TOF mode (Leco Instrumente,
Mo ¨nchengladbach, Germany) equipped with a MPS 2XL
autosampler (Gerstel, Mu ¨hlheim a.d. Ruhr, Germany). 1 mlo f
the samples was injected in splitless mode into a PTV injector
(Gerstel, Mu ¨hlheim a.d. Ruhr, Germany). After an initial time of
0.2 min at 70uC the temperature was ramped to 280uC at a rate of
12uC/s, followed by an additional constant temperature period at
280uC for 5 min. Gas-chromatography was performed on a 7890
Agilent GC over 35 min on a Vf-5MS column (30 m60.25 mm
I.D.) (Varian Deutschland, Darmstadt, Germany). Helium flow
was set to constant 1 ml/min. After 1 min at 70uC the
temperature was increased to 330uC with 10uC/min followed by
an additional constant temperature period at 330uC for 8 min.
The transfer line was set to 275uC. Ion source temperature was
275uC. Full scan mass spectra were recorded from m/z 45…600
with 20 scans/s. Solvent delay time was 325 s. Data acquisition
was done using the ChromaTOF software (version 4.24, Leco).
Data Processing and Compound Identification
Data analysis was done with Metabolite Detector (version 2.06,
[42]) or the ChromaTOF software (version 4.24, Leco). Both
software solutions support automatic deconvolution of all mass
spectra from a chromatogram and calculate the retention indices
based on the retention index marker.
In Metabolite Detector chromatograms obtained from the DSQ
II machine were afterwards analyzed in an untargeted batch
analysis. Peaks were identified by comparison of retention index
and mass spectrum to a user-defined spectra library using a cutoff
of 70% identity. Quantification was done by selected 1…3 unique
fragment ions for each individual metabolite.
In ChromaTOF, the obtained Leco GC-MS data were
analyzed at first by defining a reference chromatogram for hECCs
with the maximum number of detected peaks over a signal/noise
threshold of 30 and these compounds were added to a reference.
Additional compounds from a reference chromatogram for hESCs
were added. After that all chromatograms were matched against
the reference with a minimum match factor of 700. Compounds
annotated by retention index and mass spectra were compared to
a user defined spectra library. Selected fragment ions unique for
each individual metabolite were used for quantification.
Statistical Analysis of the Metabolome Data
A first normalization of the metabolome data was performed by
dividing the peak area of every detected compound in each sample
by the peak area of the respective internal standard ribitol. The
individual biological replicates were normalized to the same
median after averaging of the technical replicates. Derivates
belonging to one substance were summarized before further data
evaluation. Afterwards the mean, standard deviation, standard
error and relative standard error of the 4 biological samples of the
hECC and hESC samples, respectively, were calculated. Signif-
icance of concentration changes was determined using the
adjusted Bonferroni T-test [20,21].
Microarray Data
Total RNA was extracted using the MiniRNeasy Kit according
to the manufacturer’s protocol. The quality was checked by
Nanodrop analysis (Nanodrop Technologies). 500 ng were used
for biotin-labeled cRNA production using a linear amplification kit
(Ambion). Hybridizations, washing, Cy3-streptavidin staining, and
scanning were performed on the Illumina BeadStation 500
platform (Illumina) according to manufacturer’s instruction. cRNA
samples were hybridized onto Illumina human-8 BeadChips
version 3. All basic gene expression data analyses were carried
out using the BeadStudio software 3.0. Raw data were
background-subtracted, normalized using the ‘‘rank invariant’’
algorithm and then filtered for significant expression on the basis
of negative control beads. Pathway analyses were determined
according to Gene Ontology terms or mapped to KEGG
pathways and BIOCARTA pathways with DAVID 2006 [43,44]
using GenBank accession numbers represented by the correspond-
ing chip oligonucleotides as input. Then gene expression arrays
(Illumina) for genome-wide expression analysis was carried out.
The OCT4 knock down data were taken from [15].
Statistical Analysis
A groups comparison of two was made using Student’s two-
tailed t-test. Data represent the mean of triplicates and are
expressed as mean and standard deviation. All statistical analysis
was performed using the SPSS 6.0 statistical software program. P
values of ,0.05 were considered statistically significant.
Supporting Information
Table S1 Complete list of detected metabolites in
hESCs and hECCs using GC-MS.
(XLSX)
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